Exclusive | Cipla, Dr Reddy#39;s, Carlyle and Hong Kong fund in fray for Wockhardt divisions

Exclusive | Cipla, Dr Reddy#39;s, Carlyle and Hong Kong fund in fray for Wockhardt divisions Wockhardt has a diversified product portfolio with presence in therapeutic segments such as cardiology, dermatology, diabetes, respiratory and ophthalmology. It is not clear which of these divisions will be sold.

No comments:

Post a Comment